Vistagen Therapeutics, Inc. (VTGN)
4.32
+0.37
(+9.37%)
USD |
NASDAQ |
Dec 12, 14:31
Vistagen Therapeutics Research and Development Expense (TTM): 49.02M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 100.10M |
| XOMA Royalty Corp. | 2.295M |
| Omeros Corp. | 84.14M |
| GeoVax Labs, Inc. | 22.74M |
| Daré Bioscience, Inc. | 6.616M |